Neurosurgical Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
Eur Radiol. 2011 Jul;21(7):1526-34. doi: 10.1007/s00330-011-2081-y. Epub 2011 Feb 18.
Standards for residual tumour measurement after resection of gliomas with no or minimal enhancement have not yet been established. In this study residual volumes on early and late postoperative T2-/FLAIR-weighted MRI are compared.
A retrospective cohort included 58 consecutive glioma patients with no or minimal preoperative gadolinium enhancement. Inclusion criteria were first-time resection between 2007 and 2009 with a T2-/FLAIR-based target volume and availability of preoperative, early (<48 h) and late (1-7 months) postoperative MRI. The volumes of non-enhancing T2/FLAIR tissue and diffusion restriction areas were measured.
Residual tumour volumes were 22% smaller on late postoperative compared with early postoperative T2-weighted MRI and 49% smaller for FLAIR-weighted imaging. Postoperative restricted diffusion volume correlated with the difference between early and late postoperative FLAIR volumes and with the difference between T2 and FLAIR volumes on early postoperative MRI.
We observed a systematic and substantial overestimation of residual non-enhancing volume on MRI within 48 h of resection compared with months postoperatively, in particular for FLAIR imaging. Resection-induced ischaemia contributes to this overestimation, as may other operative effects. This indicates that early postoperative MRI is less reliable to determine the extent of non-enhancing residual glioma and restricted diffusion volumes are imperative.
目前尚未建立无强化或轻度强化脑胶质瘤切除术后残余肿瘤测量的标准。本研究比较了术后早期和晚期 T2-/FLAIR 加权 MRI 上的残余体积。
本回顾性队列纳入了 58 例无术前钆增强或轻度增强的连续脑胶质瘤患者。纳入标准为 2007 年至 2009 年首次切除,基于 T2-/FLAIR 的靶体积,且术前、术后早期(<48 h)和晚期(1-7 个月)MRI 可用。测量无强化 T2/FLAIR 组织和弥散受限区域的体积。
与术后早期 T2 加权 MRI 相比,晚期术后残余肿瘤体积小 22%,FLAIR 加权成像小 49%。术后受限扩散体积与早期和晚期 FLAIR 体积之间的差异以及早期 T2 和 FLAIR 体积之间的差异相关。
我们观察到术后 48 小时内 MRI 上残留无强化体积的系统且显著高估,尤其是 FLAIR 成像。切除诱导的缺血导致了这种高估,其他手术影响也可能导致这种高估。这表明,术后早期 MRI 不太可靠,不能确定非增强性残余脑胶质瘤的范围,而弥散受限体积则是至关重要的。